
Researchers say breakthrough blood cancer therapies are worth the high cost. Other experts disagree.

Researchers say breakthrough blood cancer therapies are worth the high cost. Other experts disagree.

Which life is worth saving? More and more it depends on the cost of the drug used to treat your cancer.

Debra Patt from Texas Oncology and The US Oncology Network discusses some challenges patients face when trying to enroll in the Health Insurance Marketplace.

Debra Patt, from Texas Oncology and The US Oncology Network, discusses the impact of health care reform on patients with cancer.




Anya Prince, a post-doctoral fellow at the Center for Genomics and Society at The University of North Carolina at Chapel Hill, discusses insurance coverage for preventative services.

Anya Prince, a post-doctoral fellow at the Center for Genomics and Society at The University of North Carolina at Chapel Hill, discusses insurance coverage for preventative services.

Anya Prince, a post-doctoral fellow at the Center for Genomics and Society at The University of North Carolina at Chapel Hill, discusses how insurance appeals can help a patient get the care they need.

Anya Prince, a post-doctoral fellow at the Center for Genomics and Society at The University of North Carolina at Chapel Hill, discusses how insurance appeals can help a patient get the care they need.

The possibility of going bankrupt is high on the list of concerns for more than a third of cancer patients who participated in a recently published survey by the Cancer Support Community.

Organization and help are crucial in managing finances during treatment

The Patient Protection and Affordable Care Act helps patients looking for coverage in clinical trials.